In a new study, scientists at Indian Council of Medical Research-National Institute of Virology have found that Covaxin is effective against the Brazil variant (B.1.128.2). This comes close on the heels of their recent study that had also suggested that Covaxin was effective against both the united kingdom variant and Indian (double mutant) variant B.1.617.
Presently, India is using two Covid 19 vaccines, Covaxin by Bharat Biotech and Covishield by Serum Institute of India, to vaccinate people across the country.
There is evidence suggesting that the country’s indigenous Covid-19 jab Covaxin is proving to be effective against some variants.
Dr Anthony Fauci, who is US President Joe Biden’s chief adviser on the Covid pandemic, quoted the recent Phase 3 clinical trials of Covaxin by ICMR, which claimed that the vaccine neutralises multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain (B1617) also .
In this new study posted within the bioRxiv pre-print on April 30, scientists have shown that Covaxin is effective against the Brazil variant (B.1.1.28.2).